Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Trastuzumab enters phase II trial in Paget's disease

Sep. 5, 2011

European Commission approves Afinitor for new indication

Sep. 5, 2011

New acetyl-CoA carboxylase inhibitors claimed by Bayer Schering Pharma

Sep. 5, 2011

Novel carbonic anhydrase inhibitors patented by European investigators

Sep. 2, 2011

Data presented from metastatic colorectal cohort of phase II trial of Delcath chemosaturation system

Sep. 1, 2011

Kissei obtains Japanese rights to DNA topoisomerase 2 inhibitor for anthracycline extravasation

Sep. 1, 2011

Bristol-Myers and Health Canada issue new safety information regarding Sprycel

Sep. 1, 2011

Tarceva approved in E.U. for specific subtype of non-small cell lung cancer

Sep. 1, 2011

DSMB recommends continuation of pivotal X-PECT study of perifosine

Sep. 1, 2011

First patient dosed in phase I study of ZIN ATI-001

Aug. 31, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...